NRIX: Nurix Therapeutics Inc

NRIX新闻

• 13:08 Can KYMR's Targeted Protein Degradation Pipeline Drive Future Growth?
• 12:25 SpaceX To Rally Around 85%? Here Are 10 Top Analyst Forecasts For Friday
• 10:13 HC Wainwright & Co. Maintains Buy on Nurix Therapeutics, Raises Price Target to $36
• 10:13 HC Wainwright & Co. 维持对 Nurix Therapeutics 的“买入”评级，将目标价上调至 36 美元
• 14:54 RBC Capital维持对Nurix Therapeutics的“跑赢大盘”评级，将目标价下调至35美元
• 14:54 RBC Capital Maintains Outperform on Nurix Therapeutics, Lowers Price Target to $35
• 13:26 Oppenheimer Maintains Outperform on Nurix Therapeutics, Raises Price Target to $32
• 12:48 Truist Securities维持对Nurix Therapeutics的买入评级，将目标价下调至33美元
• 12:48 Truist Securities Maintains Buy on Nurix Therapeutics, Lowers Price Target to $33
• 11:48 Baird维持对Nurix Therapeutics的“跑赢大盘”评级，将目标价上调至36美元
• 11:48 Baird Maintains Outperform on Nurix Therapeutics, Raises Price Target to $36
• 10:53 Earnings Preview: What to Expect From Gilead Sciences’ Report
• 20:25 Nurix Therapeutics, Inc. (NRIX) Q3 Earnings and Revenues Surpass Estimates
• 20:09 更正：Nurix Therapeutics 第三季度每股收益 4.73 美元，超过预估的 3.98 美元；销售额 6.73064 亿美元，超过预估的 4.11481 亿美元。
• 20:09 CORRECTION: Nurix Therapeutics Q3 EPS $4.73 Beats $3.98 Estimate, Sales $673.064M Beat $411.481M Estimate
• 20:08 Nurix Therapeutics 第三季度每股收益 4.73 美元，超过 3.98 美元预期；销售额 1990.8 万美元，低于 2428.2 万美元预期
• 17:35 10 Health Care Stocks With Whale Alerts In Today’s Session
• 06:12 Stock Market: Will S&P 500 Open Up or Down Today?